pmcc logo sml


 Here are the staff publications for May 2023.

Compiled by the Health Sciences Library (RMH, RWH, PMCC & Victorian Mental Health) 5th June 2023.


  1. Al Saffar H, Xu J, O'Brien JS, Kelly BD, Murphy DG, Lawrentschuk N. US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know? Eur Urol Open Sci 2023;52:4-6.
  2. Ali M, Wood S, Pryor D, Moon D, Bressel M, Azad AA, Mitchell C, Murphy D, Zargar H, Hardcastle N, Kearsley J, Eapen R, Wong LM, Cuff K, Lawrentschuk N, Neeson PJ, Siva S. NeoAdjuvant pembrolizumab and STEreotactic radiotherapy prior to nephrectomy for renal cell carcinoma (NAPSTER): A phase II randomised clinical trial. Contemp Clin Trials Commun 2023;33:101145.
  3. Aranza S, Roydhouse C, Mitchell C, Vissers JHA, Lo WY, Grimmond SM, Kho J. A rare diagnostically challenging case of CIC-DUX4 sarcoma arising in the neck. Pathology 2023;55:568-71.
  4. Arcos MBL, López-Campos F, Valcarcel ML, Rubio MG, de Manzanos IVF, Duque-Santana V, Aparicio MG, Martin JZ, Kishan AU, Achard V, Siva S, Couñago F. Oligometastatic Hormone-Sensitive Prostate Cancer. Why Radiotherapy? Clin Genitourin Cancer 2023;21:e93-e103.
  5. Baguley BJ, Dalla Via J, Fraser SF, Daly RM, Kiss N. Effectiveness of combined nutrition and exercise interventions on body weight, lean mass, and fat mass in adults diagnosed with cancer: a systematic review and meta-analysis. Nutr Rev 2023;81:625-46.
  6. Bergin ART, Salgado R, Loi S. Ethnicity, Immunity, and Outcomes: Biology versus Socioeconomic Status. Cancer Immunol Res 2023;11:705-6.
  7. Bhabha FK, McCormack C, Campbell BA, Lade S, Buelens O, Van Der Weyden C, Prince HM. CD30-positive lymphoproliferative disorders-An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre. Australas J Dermatol 2023;64:194-203.
  8. Bhave P, Wong J, McInerney-Leo A, Cust AE, Lawn C, Janda M, Mar VJ. Management of cutaneous melanoma in Australia: a narrative review. Med J Aust 2023;218:426-31.
  9. Bouffler SE, Lee L, Lynch F, Martyn M, Lynch E, Macciocca I, Curnow L, McCorkell G, Lunke S, Chong B, Marum JE, Delatycki M, Downie L, Goranitis I, Vears DF, Best S, Clausen M, Bombard Y, Stark Z, Gaff CL. Two-step offer and return of multiple types of additional genomic findings to families after ultrarapid trio genomic testing in the acute care setting: a study protocol. BMJ Open 2023;13:e072999.
  10. Brusco NK, Sykes K, Cheng AC, Radia-George C, Travis D, Sullivan N, Dinh T, Foster S, Thursky K. A state-wide implementation of a whole of hospital sepsis pathway with a mortality based cost-effectiveness analysis from a healthcare sector perspective. PLOS Glob Public Health 2023;3:e0000687.
  11. Dall G, Vandenberg CJ, Nesic K, Ratnayake G, Zhu W, Vissers JHA, Bedő J, Penington J, Wakefield MJ, Kee D, Carmagnac A, Lim R, Shield-Artin K, Milesi B, Lobley A, Kyran EL, O'Grady E, Tram J, Zhou W, Nugawela D, Stewart KP, Caldwell R, Papadopoulos L, Ng AP, Dobrovic A, Fox SB, McNally O, Power JD, Meniawy T, Tan TH, Collins IM, Klein O, Barnett S, Olesen I, Hamilton A, Hofmann O, Grimmond S, Papenfuss AT, Scott CL, Barker HE. Targeting homologous recombination deficiency in uterine leiomyosarcoma. J Exp Clin Cancer Res 2023;42:112.
  12. De Silva I, Wee M, Cabalag CS, Fong R, Tran K, Wu M, Schloithe A, Bright T, Duong CP, Watson DI. Para-conduit diaphragmatic hernia following esophagectomy-the new price of minimally invasive surgery? Dis Esophagus 2023;36.
  13. Deng Z, Butt T, Arhatari BD, Darido C, Auden A, Swaroop D, Partridge DD, Haigh K, Nguyen T, Haigh JJ, Carpinelli MR, Jane SM. Dysregulation of Grainyhead-like 3 expression causes widespread developmental defects. Dev Dyn 2023;252:647-67.
  14. Dhyani V, Kumar S, Manne SR, Kaur I, Jana S, Russell S, Sarkar R, Giri L. Three-Dimensional Tracking of Intracellular Calcium and Redox State during Real-Time Control in a Hypoxic Gradient in Microglia Culture: Comparison of the Channel Blocker and Reoxygenation under Ischemic Shock. ACS Chem Neurosci 2023;14:1810-25.
  15. Di Ciaccio PR, Mills G, Shipton MJ, Campbell B, Gregory G, Langfield J, Greenwood M, McKeague S, Shanavas M, Eslick R, Kidson-Gerber G, Smallbone P, Tang C, Morris K, Bilmon I, Yannakou CK, Badoux X, Berkahn L, Farina S, Mason KD, Motum P, Goss K, Hamad N. The clinical features, management and outcomes of lymphoma in pregnancy: A multicentre study by the Australasian Lymphoma Alliance. Br J Haematol 2023;201:887-96.
  16. Dinevska M, Widodo SS, Furst L, Cuzcano L, Fang Y, Mangiola S, Neeson PJ, Darcy PK, Ramsay RG, Hutchinson R, MacKay F, Christie M, Stylli SS, Mantamadiotis T. Cell signaling activation and extracellular matrix remodeling underpin glioma tumor microenvironment heterogeneity and organization. Cell Oncol (Dordr) 2023;46:589-602.
  17. Everitt R, Wong AK, Wawryk O, Le B, Yoong J, Pisasale M, Mendis R, Philip J. A multi-centre study on patients dying from COVID-19: communication between clinicians, patients and their families. Intern Med J 2022;52:2068-75.
  18. Feely K, Edbrooke L, Bower W, Mazzone S, Merolli M, Staples J, Martin A. Allied health professionals' experiences and lessons learned in response to a big bang electronic medical record implementation: A prospective observational study. Int J Med Inform 2023;176:105094.
  19. Feng Y, Yang T, Zhu J, Li M, Doyle M, Ozcoban V, Bass GT, Pizzolla A, Cain L, Weng S, Pasam A, Kocovski N, Huang YK, Keam SP, Speed TP, Neeson PJ, Pearson RB, Sandhu S, Goode DL, Trigos AS. Spatial analysis with SPIAT and spaSim to characterize and simulate tissue microenvironments. Nat Commun 2023;14:2697.
  20. Fleming CA, Mohan HM, O'Leary DP, Corrigan M, Redmond HP. Metabolomic Pathway Activity with Genomic Single-Nucleotide Polymorphisms Associated with Colorectal Cancer Recurrence and 5-Year Overall Survival. J Gastrointest Cancer 2023;54:247-58.
  21. Grimm L, Mason E, Yu H, Dudczig S, Panara V, Chen T, Bower NI, Paterson S, Rondon Galeano M, Kobayashi S, Senabouth A, Lagendijk AK, Powell J, Smith KA, Okuda KS, Koltowska K, Hogan BM. Single-cell analysis of lymphatic endothelial cell fate specification and differentiation during zebrafish development. Embo j 2023;42:e112590.
  22. Gudenkauf LM, Chavez MN, Maconi ML, Geiss C, Seyedroudbari A, Thin P, Hoogland AI, Nguyen K, Murthy V, Armstrong WR, Komrokji K, Oswald LB, Jim HSL, El-Haddad G, Fendler WP, Herrmann K, Cella D, Czernin J, Hofman MS, Dicker AP, Calais J, Tagawa ST, Gonzalez BD. Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer. J Nucl Med 2023;64:869-72.
  23. Holmes OS, Ellen S, Smallwood N, Willis K, Delaney C, Worth LJ, Dolan S, Dunlop L, McDonald G, Karimi L, Rees M, Ftanou M. The Psychological and Wellbeing Impacts of Quarantine on Frontline Workers during COVID-19 and Beyond. Int J Environ Res Public Health 2023;20.
  24. Hoque SS, Zhou J, Gartoulla P, Hansen J, Farrell G, Hopper I. Comparing Direct-to-Implant and Two-Stage Breast Reconstruction in the Australian Breast Device Registry. Plast Reconstr Surg 2023;151:927-37.
  25. Khan A, Wong J, Riedel B, Laing E, Beaumont A, Kong J, Warrier S, Heriot A. The Impact of Peri-operative Enteral Immunonutrition on Post-operative Complications in Gastrointestinal Cancer Surgery: A Meta-Analysis. Ann Surg Oncol 2023;30:3619-31.
  26. Khan A, Wong J, Riedel B, Laing E, Beaumont A, Kong J, Warrier S, Heriot A. ASO Visual Abstract: The Impact of Perioperative Enteral Immunonutrition on Postoperative Complications in Astrointestinal Cancer Surgery: A Meta-Analysis. Ann Surg Oncol 2023;30:3632-3.
  27. Khanina A, Douglas AP, Yeoh DK, So M, Abbotsford J, Spelman T, Kong DCM, Slavin MA, Thursky KA. Validation of the Antifungal National Antimicrobial Prescribing Survey (AF-NAPS) quality assessment tool. J Antimicrob Chemother 2023;78:1367-77.
  28. Koch MK, Ravichandran A, Murekatete B, Clegg J, Joseph MT, Hampson M, Jenkinson M, Bauer HS, Snell C, Liu C, Gough M, Thompson EW, Werner C, Hutmacher DW, Haupt LM, Bray LJ. Exploring the Potential of PEG-Heparin Hydrogels to Support Long-Term Ex Vivo Culture of Patient-Derived Breast Explant Tissues. Adv Healthc Mater 2023;12:e2202202.
  29. Larkins K, Mansour K, Costello D, Gray M, Warrier S, Heriot A, Mohan H. Recommendations for the design of video-based educational interventions as instructional tools in robotic surgical training. J Robot Surg 2023;17:779-84.
  30. Larkins KM, Mohan HM, Gray M, Costello DM, Costello AJ, Heriot AG, Warrier SK. Transferability of robotic console skills by early robotic surgeons: a multi-platform crossover trial of simulation training. J Robot Surg 2023;17:859-67.
  31. Luo X, Maciaszek JL, Thompson BA, Leong HS, Dixon K, Sousa S, Anderson M, Roberts ME, Lee K, Spurdle AB, Mensenkamp AR, Brannan T, Pardo C, Zhang L, Pesaran T, Wei S, Fasaye GA, Kesserwan C, Shirts BH, Davis JL, Oliveira C, Plon SE, Schrader KA, Karam R. Optimising clinical care through CDH1-specific germline variant curation: improvement of clinical assertions and updated curation guidelines. J Med Genet 2023;60:568-75.
  32. Manos K, Chong G, Keane C, Lee ST, Smith C, Churilov L, McKendrick J, Renwick W, Blombery P, Burgess M, Nelson NE, Fancourt T, Hawking J, Lin W, Scott AM, Barraclough A, Wight J, Grigg A, Fong CY, Hawkes EA. Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study. Leukemia 2023;37:1092-102.
  33. McArthur GA. Combination Immune Checkpoint Inhibition: Is First Line Best? J Clin Oncol 2023;41:2691-4.
  34. Mileshkin LR, Moore KN, Barnes EH, Gebski V, Narayan K, King MT, Bradshaw N, Lee YC, Diamante K, Fyles AW, Small W, Jr., Gaffney DK, Khaw P, Brooks S, Thompson JS, Huh WK, Mathews CA, Buck M, Suder A, Lad TE, Barani IJ, Holschneider CH, Van Dyk S, Quinn M, Rischin D, Monk BJ, Stockler MR. Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial. Lancet Oncol 2023;24:468-82.
  35. Mills GS, Chadwick V, Tang C, Perram J, Anderson MA, Anazodo A, Kidson-Gerber G, Shand A, Lavee O, Withers B, Milliken S, Di Ciaccio PR, Hamad N. Immunochemotherapy for life-threatening haematological malignancies in pregnancy: a systematic review of the literature and cross-sectional analysis of clinical trial eligibility. Lancet Haematol 2023;10:e458-e67.
  36. Moso MA, Sasadeusz J, Morrissey CO, Bond K, Guy S, Slavin MA, Dendle C. Survey of treatment practices for immunocompromised patients with COVID-19 in Australasia. Intern Med J 2023;53:619-24.
  37. Mulazzani E, Kong K, Arostegui JI, Ng AP, Ranathunga N, Abeysekera W, Garnham AL, Ng SL, Baker PJ, Jackson JT, Lich JD, Hibbs ML, Wicks IP, Louis C, Masters SL. G-CSF drives autoinflammation in APLAID. Nat Immunol 2023;24:814-26.
  38. Muranen TA, Morra A, Khan S, Barnes DR, Bolla MK, Dennis J, Keeman R, Leslie G, Parsons MT, Wang Q, Ahearn TU, Aittomäki K, Andrulis IL, Arun BK, Behrens S, Bialkowska K, Bojesen SE, Camp NJ, Chang-Claude J, Czene K, Devilee P, Domchek SM, Dunning AM, Engel C, Evans DG, Gago-Dominguez M, García-Closas M, Gerdes AM, Glendon G, Guénel P, Hahnen E, Hamann U, Hanson H, Hooning MJ, Hoppe R, Izatt L, Jakubowska A, James PA, Kristensen VN, Lalloo F, Lindeman GJ, Mannermaa A, Margolin S, Neuhausen SL, Newman WG, Peterlongo P, Phillips KA, Pujana MA, Rantala J, Rønlund K, Saloustros E, Schmutzler RK, Schneeweiss A, Singer CF, Suvanto M, Tan YY, Teixeira MR, Thomassen M, Tischkowitz M, Tripathi V, Wappenschmidt B, Zhao E, Easton DF, Antoniou AC, Chenevix-Trench G, Pharoah PDP, Schmidt MK, Blomqvist C, Nevanlinna H. PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants. NPJ Breast Cancer 2023;9:37.
  39. Neoh CF, Jeong W, Kong DC, Slavin MA. The antifungal pipeline for invasive fungal diseases: what does the future hold? Expert Rev Anti Infect Ther 2023;21:577-94.
  40. Noori T, Rudd-Schmidt JA, Kane A, Frith K, Gray PE, Hu H, Hsu D, Chung CWT, Hodel AW, Trapani JA, Voskoboinik I. A cell-based functional assay that accurately links genotype to phenotype in familial HLH. Blood 2023;141:2330-42.
  41. Nowak AK, Newton RU, Cruickshank T, Cormie P, Halkett GKB, Tsoi D, Galvão DA. A feasibility, safety, and efficacy evaluation of supervised aerobic and resistance exercise for patients with glioblastoma undertaking adjuvant chemoradiotherapy. Neurooncol Pract 2023;10:261-70.
  42. Ong AJS, Bladen CE, Tigani TA, Karamalakis AP, Evason KJ, Brown KK, Cox AG. The KEAP1-NRF2 pathway regulates TFEB/TFE3-dependent lysosomal biogenesis. Proc Natl Acad Sci U S A 2023;120:e2217425120.
  43. Pasricha SR, Mwangi MN, Moya E, Ataide R, Mzembe G, Harding R, Zinenani T, Larson LM, Demir AY, Nkhono W, Chinkhumba J, Simpson JA, Clucas D, Stones W, Braat S, Phiri KS. Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial. Lancet 2023;401:1595-609.
  44. Petrie M, Kelly H, Jefford M. Do Australian state and territory cancer plans include survivorship-related objectives and propose quality survivorship outcomes and measures? Aust Health Rev 2023;47:291-300.
  45. Rickard JA, Rogers TM, Westerman DA, Carolan C, Fox SB. Identification errors in medical research: Privacy at all costs? Contemp Clin Trials 2023;130:107206.
  46. Sakuma M, Blombery P, Meggendorfer M, Haferlach C, Lindauer M, Martens UM, Kern W, Haferlach T, Walter W. Novel causative variants of VEXAS in UBA1 detected through whole genome transcriptome sequencing in a large cohort of hematological malignancies. Leukemia 2023;37:1080-91.
  47. Sathianathen NJ, Pan HYC, Lawrentschuk N, Siva S, Azad AA, Tran B, Bolton D, Murphy DG. Emergence of triplet therapy for metastatic castration-sensitive prostate cancer: An updated systematic review and network meta-analysis. Urol Oncol 2023;41:233-9.
  48. Sayed S, Koka H, Abubakar M, Gardner K, Salgado R, Moloo Z, Caban-Ureña AB, Rosen D, Castro P, Saleh M, Shaikh AJ, Shah J, Figueroa J, Makokha F, Ha HK, Wang Z, Magangane P, Naidoo R, Ngundo V, Yang XR, Govender D. Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics. Breast Cancer Res Treat 2023;199:401-13.
  49. Seifert R, Rasul S, Seitzer K, Eveslage M, Rahbar Nikoukar L, Kessel K, Schafers M, Yu J, Haug AR, Hacker M, Bogemann M, Bodei L, Morris MJ, Hofman MS, Rahbar K. A Prognostic Risk Score for Prostate Cancer Based on PSMA PET-derived Organ-specific Tumor Volumes. Radiology 2023;307:e222010.
  50. Sim S, Kalff A, Tuch G, Mollee P, Ho PJ, Harrison S, Gibbs S, Prince HM, Spencer A, Joshua D, Lee C, Ling S, Murphy N, Szabo F, Szer J, Weber N, Ward C, Talaulikar D, Zannettino A, Quach H. The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma Australia. Intern Med J 2023;53:819-24.
  51. Siva S, Solomon BJ. Metastatic Ablation in Epidermal Growth Factor Receptor Mutated Oligometastatic Non-Small Cell Lung Cancer-Upfront or Outback After Systemic Tyrosine Kinase Inhibitors? Int J Radiat Oncol Biol Phys 2023;116:481-2.
  52. Skrabal Ross X, McDonald FEJ, Konings S, Schiena E, Phipps-Nelson J, Hodgson F, Patterson P. Cancer patients as parents: implementation of a cross sector service for families with adolescent and young adult children. BMC Health Serv Res 2023;23:472.
  53. Socié G, Niederwieser D, von Bubnoff N, Mohty M, Szer J, Or R, Garrett J, Prahallad A, Wilke C, Zeiser R. Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysis. Blood 2023;141:2771-9.
  54. Solier S, Muller S, Caneque T, Versini A, Mansart A, Sindikubwabo F, Baron L, Emam L, Gestraud P, Pantos GD, Gandon V, Gaillet C, Wu TD, Dingli F, Loew D, Baulande S, Durand S, Sencio V, Robil C, Trottein F, Pericat D, Naser E, Cougoule C, Meunier E, Begue AL, Salmon H, Manel N, Puisieux A, Watson S, Dawson MA, Servant N, Kroemer G, Annane D, Rodriguez R. A druggable copper-signalling pathway that drives inflammation. Nature 2023;617:386-94.
  55. Spain L, Coulton A, Lobon I, Rowan A, Schnidrig D, Shepherd STC, Shum B, Byrne F, Goicoechea M, Piperni E, Au L, Edmonds K, Carlyle E, Hunter N, Renn A, Messiou C, Hughes P, Nobbs J, Foijer F, van den Bos H, Wardenaar R, Spierings DCJ, Spencer C, Schmitt AM, Tippu Z, Lingard K, Grostate L, Peat K, Kelly K, Sarker S, Vaughan S, Mangwende M, Terry L, Kelly D, Biano J, Murra A, Korteweg J, Lewis C, O'Flaherty M, Cattin AL, Emmerich M, Gerard CL, Pallikonda HA, Lynch J, Mason R, Rogiers A, Xu H, Huebner A, McGranahan N, Al Bakir M, Murai J, Naceur-Lombardelli C, Borg E, Mitchison M, Moore DA, Falzon M, Proctor I, Stamp GWH, Nye EL, Young K, Furness AJS, Pickering L, Stewart R, Mahadeva U, Green A, Larkin J, Litchfield K, Swanton C, Jamal-Hanjani M, Turajlic S. Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways. Cancer Discov 2023;13:1364-85.
  56. Sulit AK, Wilson K, Pearson J, Silander OK, Sampurno S, Michael M, Ramsay R, Heriot A, Frizelle F, Purcell RV. Human gene and microbial analyses in rectal cancer complete responses to radiotherapy. BJS Open 2023;7.
  57. Takano EA, Younes MM, Meehan K, Spalding L, Yan M, Allan P, Fox SB, Redfern A, Clouston D, Giles GG, Christie EL, Anderson RL, Zethoven M, Phillips KA, Gorringe K, Britt KL. Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival. BMC Cancer 2023;23:459.
  58. Talaulikar D, Joshua D, Ho PJ, Gibson J, Quach H, Gibbs S, Ling S, Ward C, Augustson BM, Trotman J, Harrison SJ, Tam CS, Medical, Scientific Advisory Group MA. Treatment of patients with Waldenstrom macroglobulinaemia: clinical practice update from the Myeloma Foundation of Australia Medical and Scientific Advisory Group. Intern Med J 2023;53:599-609.
  59. Thompson JR, Lai-Kwon J, Morton RL, Guminski AD, Gonzalez M, Atkinson V, Sandhu S, Brown MP, Menzies AM, McArthur GA, Lo SN, Long GV, Bartula I. Health-related quality of life in patients with melanoma brain metastases treated with immunotherapy. Immunotherapy 2023;15:593-610.
  60. To YH, Degeling K, McCoy M, Wong R, Jones I, Dunn C, Hong W, Loft M, Gibbs P, Tie J. Real-world adjuvant chemotherapy treatment patterns and outcomes over time for resected stage II and III colorectal cancer. Asia Pac J Clin Oncol 2023;19:392-402.
  61. van Gool K, Hall J, Haywood P, Liu D, Yu S, Webster SBG, Moradi B, Aranda S. Higher fees and out-of-pocket costs in radiotherapy point to a need for funding reform. Aust Health Rev 2023;47:301-6.
  62. Vitale I, Pietrocola F, Guilbaud E, Aaronson SA, Abrams JM, Adam D, Agostini M, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Aqeilan RI, Arama E, Baehrecke EH, Balachandran S, Bano D, Barlev NA, Bartek J, Bazan NG, Becker C, Bernassola F, Bertrand MJM, Bianchi ME, Blagosklonny MV, Blander JM, Blandino G, Blomgren K, Borner C, Bortner CD, Bove P, Boya P, Brenner C, Broz P, Brunner T, Damgaard RB, Calin GA, Campanella M, Candi E, Carbone M, Carmona-Gutierrez D, Cecconi F, Chan FK, Chen GQ, Chen Q, Chen YH, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Ciliberto G, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D'Angiolella V, Daugaard M, Dawson TM, Dawson VL, De Maria R, De Strooper B, Debatin KM, Deberardinis RJ, Degterev A, Del Sal G, Deshmukh M, Di Virgilio F, Diederich M, Dixon SJ, Dynlacht BD, El-Deiry WS, Elrod JW, Engeland K, Fimia GM, Galassi C, Ganini C, Garcia-Saez AJ, Garg AD, Garrido C, Gavathiotis E, Gerlic M, Ghosh S, Green DR, Greene LA, Gronemeyer H, Hacker G, Hajnoczky G, Hardwick JM, Haupt Y, He S, Heery DM, Hengartner MO, Hetz C, Hildeman DA, Ichijo H, Inoue S, Jaattela M, Janic A, Joseph B, Jost PJ, Kanneganti TD, Karin M, Kashkar H, Kaufmann T, Kelly GL, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Kluck R, Krysko DV, Kulms D, Kumar S, Lavandero S, Lavrik IN, Lemasters JJ, Liccardi G, Linkermann A, Lipton SA, Lockshin RA, Lopez-Otin C, Luedde T, MacFarlane M, Madeo F, Malorni W, Manic G, Mantovani R, Marchi S, Marine JC, Martin SJ, Martinou JC, Mastroberardino PG, Medema JP, Mehlen P, Meier P, Melino G, Melino S, Miao EA, Moll UM, Munoz-Pinedo C, Murphy DJ, Niklison-Chirou MV, Novelli F, Nunez G, Oberst A, Ofengeim D, Opferman JT, Oren M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pentimalli F, Pereira DM, Pervaiz S, Peter ME, Pinton P, Porta G, Prehn JHM, Puthalakath H, Rabinovich GA, Rajalingam K, Ravichandran KS, Rehm M, Ricci JE, Rizzuto R, Robinson N, Rodrigues CMP, Rotblat B, Rothlin CV, Rubinsztein DC, Rudel T, Rufini A, Ryan KM, Sarosiek KA, Sawa A, Sayan E, Schroder K, Scorrano L, Sesti F, Shao F, Shi Y, Sica GS, Silke J, Simon HU, Sistigu A, Stephanou A, Stockwell BR, Strapazzon F, Strasser A, Sun L, Sun E, Sun Q, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Troy CM, Turk B, Urbano N, Vandenabeele P, Vanden Berghe T, Vander Heiden MG, Vanderluit JL, Verkhratsky A, Villunger A, von Karstedt S, Voss AK, Vousden KH, Vucic D, Vuri D, Wagner EF, Walczak H, Wallach D, Wang R, Wang Y, Weber A, Wood W, Yamazaki T, Yang HT, Zakeri Z, Zawacka-Pankau JE, Zhang L, Zhang H, Zhivotovsky B, Zhou W, Piacentini M, Kroemer G, Galluzzi L. Apoptotic cell death in disease-Current understanding of the NCCD 2023. Cell Death Differ 2023;30:1097-154.
  63. Wang TH, Tokhi A, Gharibans A, Evennett N, Beban G, Schamberg G, Varghese C, Calder S, Duong C, O'Grady G. Non-invasive thoracoabdominal mapping of postoesophagectomy conduit function. BJS Open 2023;7.
  64. Westin JR, Locke FL, Dickinson M, Ghobadi A, Elsawy M, van Meerten T, Miklos DB, Ulrickson ML, Perales MA, Farooq U, Wannesson L, Leslie L, Kersten MJ, Jacobson CA, Pagel JM, Wulf G, Johnston P, Rapoport AP, Du L, Vardhanabhuti S, Filosto S, Shah J, Snider JT, Cheng P, To C, Oluwole OO, Sureda A. Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma. Clin Cancer Res 2023;29:1894-905.
  65. Wichmann CW, Poniger S, Guo N, Roselt P, Rudd SE, Donnelly PS, Blyth B, Van Zuylekom J, Rigopoulos A, Burvenich IJG, Morandeau L, Mohamed S, Nowak A, Hegi-Johnson F, MacManus M, Scott AM. Automated radiosynthesis of [(89)Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo. Nucl Med Biol 2023;120-121:108351.
  66. Wu MY, Shepherd STC, Fendler A, Carr EJ, Au L, Harvey R, Dowgier G, Hobbs A, Herman LS, Ragno M, Adams L, Schmitt AM, Tippu Z, Shum B, Farag S, Rogiers A, O'Reilly N, Bawumia P, Smith C, Carlyle E, Edmonds K, Del Rosario L, Lingard K, Mangwende M, Holt L, Ahmod H, Korteweg J, Foley T, Barber T, Hepworth S, Emslie-Henry A, Caulfield-Lynch N, Byrne F, Deng D, Williams B, Brown M, Caidan S, Gavrielides M, MacRae JI, Kelly G, Peat K, Kelly D, Murra A, Kelly K, O'Flaherty M, Popat S, Yousaf N, Jhanji S, Tatham K, Cunningham D, Van As N, Young K, Furness AJS, Pickering L, Beale R, Swanton C, Gandhi S, Gamblin S, Bauer DLV, Kassiotis G, Howell M, Walker S, Nicholson E, Larkin J, Wall EC, Turajlic S. Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer. Cancer Cell 2023;41:821-3.
  67. Yanes T, Wallingford CK, Young MA, McInerney-Leo AM, Willis AM, McKnight L, Terrill B, McInerny S, Forrest LE, Cicciarelli L, Williams R, Keane H, James PA. Development and evaluation of a novel educational program for providers on the use of polygenic risk scores. Genet Med 2023;25:100876.
  68. Zantomio D, Bayly E, Wong K, Spencer A, Ritchie D, Morgan S, Kelsey G, Dennington PM. Centre-based comparison of double versus single prevention strategy on transfusion-transmitted cytomegalovirus in at-risk haemopoietic stem cell transplant patients and a state survey on cytomegalovirus-seronegative ordering practises. Intern Med J 2023;53:717-22.

Contact Details and Hours

(03) 9138 0580
(03) 9342 8615
M - F: 8:30am - 5pm

Library Manager

Susan Monaghan

Health Sciences Library

Royal Melbourne Hospital – City Campus

Ground floor - North

Grattan Street


Learning Resource Centre

Level 7A, Peter MacCallum Cancer Centre

305 Grattan Street